April 13, 2026 Real-Time Surveillance System for Patient Deterioration: A Randomized Controlled Trial
April 7, 2026 Isatuximab Improves MRD Negativity in Newly Diagnosed Multiple Myeloma: EMN24 IsKia Trial Results